Location: Home
  • search
  • go
  • Relate News
  • 9/26/2019Sanofi, AZ, Lilly and More Win Business in China's Expanded Cut-price ...
  • 9/26/2019NHSA: BMI Reimbursed Nearly CNY 2B for 17 Anticancers in H1
  • 9/25/2019CDE Solicits Comments over Two Guidelines on Clinical Data Monitoring ...
  • 9/25/2019NMPA Officially Joins IMDRF NCAR Exchange Program
  • 9/24/2019China to Promote Vaccination against Cervical Cancer
  • 9/24/2019China's Tech Giants Take a Shot at Reinventing Health Care
  • 9/24/2019Mitsubishi Tanabe Files for Tenelia (Teneligliptin) Approval in China
  • 9/24/2019Helsinn and Mundipharma Jointly Announce NMPA's Approval of Oral Formu...
  • 9/24/2019NMPA Co-sponsors 5th China-ASEAN Summit for Drug Development and Coope...
  • 9/24/2019Caixin: Dr Reddy’s Is First Indian Drugmaker Accepted by China's 4+7 ...
  • 9/24/2019Bloomberg: China’s Drug-Price Cuts Pressure Lipitor and Other Foreign...
  • 9/24/2019China Expands 4+7 Drug Trial, Putting More Pressure on Pharma Cos
  • 9/23/2019China to Establish National Surveillance System for Pediatric Cancers
  • 9/23/2019Xynomic Pharma Wins FDA Fast-Track Designation of Abexinostat for Foll...
  • 9/23/2019China to Promote Medical and Senior Care Integration
  • 9/23/2019China Issues Implementation Plan for Cancer Prevention and Treatment u...
  • 9/23/2019Big Pharma Seen Unlikely To Gain From China's Revised Drug Purchase Po...
  • 9/20/2019Recent Executive Moves
  • 9/20/2019Advanced Aesthetic Technologies and CNBG Announce Strategic Cooperatio...
  • 9/20/2019Clinical Investigation Begins for China-developed Novel Chronic Pain R...
  • 9/20/2019Shanghai Pharma and BIOCAD to Set Up $400M Joint Venture
  • 9/20/2019MicuRx Reports Positive Top-line Results of a China Phase 3 Trial for ...
  • 9/19/2019China Biologic Receives $4.6 Billion Buyout Offer
  • 9/19/2019Covance Unveils New R&D Center in Shanghai
  • 9/19/2019ASLAN Pharma Presents China Phase 2 Data for Varlitinib in Second Line...
  • 9/19/2019Shanghai Henlius Biotech Raises $410M in Hong Kong IPO Despite Unrest
  • 9/19/2019AstraZeneca and Ironwood Pharma Amend LINZESS (linaclotide) Collaborat...
  • 9/18/2019NMPA Issues Technical Guidelines for Late Term Non-Small Cell Lung Can...
  • 9/17/2019Parexel Expands Phase I Research Capabilities in China
  • 9/17/2019New Policy Expected to Hasten Approval of Foreign Drugs and Medical De...
  • Page:211/720 Total number of articles:21572: [First][<<] [209] [210] [211] [212] [213] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group